Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as Adjuvant to Levo-bupivacaine in Infraclavicular Brachial Plexus Block
NCT04729868Completed
- Sponsor
- Aswan University Hospital
- Start
- Apr 2017
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in Acquired deformity of upper extremity (3 arms), sponsored by Aswan University Hospital. Primary endpoints: Onset time of sensory block at 45 minutes, Onset time of motor blockade at 24 hours and 2 more. Started Apr 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Acquired deformity of upper extremity
Beyond the preview
Go deeper on NCT04729868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04729868.